Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Am J Cardiol. 2024 Dec 15;233:1-6. doi: 10.1016/j.amjcard.2024.09.021. Epub 2024 Sep 28.
Hypertension has been associated with worse outcomes in patients with familial hypercholesterolemia (FH). We aimed to identify the clinical impact of blood pressure management on the development of cardiovascular events. We assessed patients with clinically diagnosed heterozygous FH (n = 1,273, male/female = 614/659) with blood pressure data. We categorized them into 4 groups (group 1: patients without hypertension from baseline to follow-up; group 2: patients without hypertension at baseline but in whom hypertension developed at follow-up; group 3: patients with hypertension at baseline that was well-controlled at follow-up; group 4: patients with hypertension from baseline that was uncontrolled at follow-up). We used Cox proportional hazards models to evaluate factors associated with cardiovascular events, including cardiovascular death and any coronary events. The median follow-up period was 10.9 years. We observed 142 cardiovascular events during the follow-up period and revealed that blood pressure management was significantly associated with cardiovascular event occurrence (hazard ratio [HR] 2.50, 95% confidence interval [CI] 1.30 to 3.70, p <0.001; HR 4.18, 95% CI 2.08 to 6.28, p <0.001; HR 10.96, 95% CI 6.10 to 17.58, p <0.001 in groups 2, 3, and 4, respectively, with group 1 as reference). In conclusion, blood pressure management is crucial in patients with heterozygous FH.
高血压与家族性高胆固醇血症(FH)患者的预后较差有关。我们旨在确定血压管理对心血管事件发展的临床影响。我们评估了有临床诊断的杂合子 FH 患者(n=1273,男/女=614/659)的血压数据。我们将他们分为 4 组(第 1 组:基线至随访期间无高血压的患者;第 2 组:基线无高血压但随访时出现高血压的患者;第 3 组:基线有高血压但随访时血压控制良好的患者;第 4 组:基线有高血压且随访时血压控制不佳的患者)。我们使用 Cox 比例风险模型评估与心血管事件相关的因素,包括心血管死亡和任何冠状动脉事件。中位随访时间为 10.9 年。我们在随访期间观察到 142 例心血管事件,结果表明血压管理与心血管事件的发生显著相关(风险比 [HR] 2.50,95%置信区间 [CI] 1.30 至 3.70,p<0.001;HR 4.18,95%CI 2.08 至 6.28,p<0.001;HR 10.96,95%CI 6.10 至 17.58,分别在第 2、3 和 4 组中,以第 1 组为参照)。总之,血压管理对杂合子 FH 患者至关重要。